XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated statements of cash flows - CNY (¥)
 6 Months Ended 12 Months Ended
Dec. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities        
Cash generated from operations ¥ 1,448,307,000 ¥ 2,084,952,000 ¥ 1,636,392,000 ¥ 1,111,031,000
Income tax paid (350,766,000) (418,922,000) (230,130,000) (194,711,000)
Net cash from operating activities 1,097,541,000 1,666,030,000 1,406,262,000 916,320,000
Cash flows from investing activities        
Payment for purchases of property, plant, equipment and intangible assets (264,766,000) (174,147,000) (290,108,000) (180,279,000)
Payment for acquisition of land use right     (944,099,000)  
Proceeds from disposal of property, plant and equipment and intangible assets 427,000 5,224,000 351,000 4,323,000
Refund of prepayments   200,000,000    
Payments for purchases of other investments (2,553,982,000) (7,880,763,000) (12,627,323,000) (28,887,790,000)
Proceeds from disposal of other investments 2,503,982,000 7,808,395,000 12,525,477,000 28,787,790,000
Placement of term deposits (210,405,000) (761,371,000) (236,878,000)  
Release of term deposits 581,371,000 316,542,000    
Interest income 122,231,000 145,225,000 66,344,000 40,433,000
Investment income from other investments 14,281,000 42,921,000 63,801,000 66,837,000
Proceeds from repayment from related parties       14,713,000
Payments for investments in equity-accounted investees (16,066,000)     (356,000,000)
Acquisition of subsidiaries, net of cash acquired   4,568,000 (683,483,000) (8,824,000)
Net cash (used in)/from investing activities 177,073,000 (293,406,000) (2,125,918,000) (518,797,000)
Cash flows from financing activities        
Proceeds from initial public offering and exercise of the over-allotment option, net of underwriting commissions and other issuance costs       4,178,860,000
Proceeds from Hong Kong public offering and exercise of the over-allotment option, net of underwriting commissions and other issuance costs   469,683,000    
Proceeds from capital injection from shareholders, subscription of restricted shares, restricted share units and exercise of options 168,000 382,000 589,000 2,795,000
Proceeds from loans and borrowings       313,000
Repayment of loans and borrowings   (206,000) (5,295,000) (416,588,000)
Repayment to the controlling shareholder       (11,946,000)
Payment of capital element and interest element of lease liabilities (236,519,000) (346,008,000) (317,017,000) (215,762,000)
Payments of repurchase of shares (73,560,000) (32,711,000) (82,160,000)  
Prepayments for repurchase of shares (87,324,000) (3,693,000) (3,375,000)  
Interest paid     (1,000,000) (1,488,000)
Dividends paid (923,664,000) (370,787,000) (306,255,000)  
Payments of listing expenses relating to Hong Kong public offering   (42,616,000) (19,046,000)  
Net cash from/(used in) financing activities (1,320,899,000) (325,956,000) (733,559,000) 3,536,184,000
Net increase/(decrease) in cash and cash equivalents (46,285,000) 1,046,668,000 (1,453,215,000) 3,933,707,000
Cash and cash equivalents at the beginning of the year/period 6,489,213,000 5,348,492,000 6,771,653,000 2,853,980,000
Effect of movements in exchange rates on cash held (27,487,000) 94,053,000 30,054,000 (16,034,000)
Cash and cash equivalents at the end of the year/period ¥ 6,415,441,000 ¥ 6,489,213,000 ¥ 5,348,492,000 ¥ 6,771,653,000